Thalassaemia major: the murky story of deferiprone.
D003676:Deferoxamine / Q000627:therapeutic use*; D004345:Drug Industry; D004992:Ethics, Medical; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000188:drug therapy*
D007502:Iron Chelating Agents; D003676:Deferoxamine